Last reviewed · How we verify

NCT07365696

Fatigue and Cognitive Dysfunction Due to Synaptopathy or Graft Versus Host (GVH) Disease in the Brain.

Recruiting now Last updated 26 January 2026
What this trial tests

trial testing PET investigation in Fatigue in 30 participants. Currently enrolling.

Timeline
28 November 2023
Primary endpoint
28 December 2027
28 December 2028

Quick facts

Lead sponsorKarolinska University Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment30
Start date28 November 2023
Primary completion28 December 2027
Estimated completion28 December 2028
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska University Hospital

Who can join

Adults 20 to 75, any sex, with Fatigue or Graft Vs Host Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients undergoing allogenic stem cell transplantation are regularly followed up in the outpatient clinic at Karolinska University Hospital. Here, patients are offered participation the fatigue study measuring both fatigue and cognitive impairment systematically by international standard. Meanwhile liquor samples and advanced PET imaging techniques are available for these patients as part of a research project allowing extensive immunological and radio-morphological studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fatigue

Currently open trials in the same condition.

Other Karolinska University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07365696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing